Three-dimensional echocardiography for the evaluation of hypertrophic cardiomyopathy patients: relation to symptoms and exercise capacity

The International Journal of Cardiovascular Imaging - Tập 39 Số 12 - Trang 2475-2481
I Cardoso1, J Viegas1, Sílvia Aguiar Rosa1, P Garcia Bras1, A Grazina1, Inês Cruz2, Luísa Moura Branco1, A Galrinho1, António Fiarresga1, Luís Rocha Lopes3, Rui Cruz Ferreira1
1Department of Cardiology, Santa Marta Hospital, Lisbon, Portugal
2Hospital Garcia de Orta, Almada, Portugal
3Inherited Cardiac Disease Unit, Bart’s Heart Centre, St Bartholomew´s Hospital, London, UK

Tóm tắt

AbstractPatients with hypertrophic cardiomyopathy may exhibit impaired functional capacity, associated with increased morbidity and mortality. Systolic function is one of the determinants of functional capacity. Early identification of systolic disfunction may identify patients at risk for adverse outcomes. Myocardial deformation parameters, derived from three-dimensional (3D) speckle-tracking echocardiography (3DSTE) are useful tools to assess left ventricular systolic function, and are often abnormal before a decline in ejection fraction is seen. The aim of this study was to evaluate the correlation between myocardial deformation parameters obtained by 3DSTE and functional capacity in patients with hypertrophic cardiomyopathy. Seventy-four hypertrophic cardiomyopathy adult patients were prospectively evaluated. All patients underwent a dedicated 2D and 3D echocardiographic examination and cardiopulmonary exercise testing (CPET). Values of 3D global radial (GRS), longitudinal (3DGLS) and circumferential strain (GCS) were overall reduced in our population: 99% (n = 73) of the patients had reduced GLS, 82% (n = 61) had reduced GRS and all patients had reduced GCS obtain by 3DSTE. Average peak VO2 was 21.01 (6.08) ml/Kg/min; 58% (n = 39) of the patients showed reduced exercise tolerance (predicted peak VO2 < 80%). The average VE/VCO2 slope was 29.0 (5.3) and 16% (n = 11) of the patients had impaired ventilatory efficiency (VE/VCO2 > 34). In multivariable analysis, 3D GLS (β1 = 0.10, 95%CI: 0.03;0.23, p = 0.014), age (β1 = -0.15, 95%CI: -0.23; -0.05, p = 0.002) and female gender (β1 = -5.10, 95%CI: -7.7; -2.6, p < 0.01) were independently associated with peak VO2. No association was found between left ventricle ejection fraction obtain and peak VO2 (r = 0.161, p = 0.5). Impaired myocardial deformation parameters evaluated by 3DSTE were associated with worse functional capacity assessed by peak VO2.

Từ khóa


Tài liệu tham khảo

Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents and the European Society of Cardiology Committee for Practice Guidelines. Journal of the American College of Cardiology. Elsevier Inc., pp 1687–1713

McLeod CJ, Bos JM, Theis JL et al (2009) Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J 158:799–805. https://doi.org/10.1016/j.ahj.2009.09.006

Magrì D, Re F, Limongelli G et al (2016) Heart failure progression in hypertrophic cardiomyopathy - possible insights from cardiopulmonary exercise testing. Circ J 80:2204–2211. https://doi.org/10.1253/circj.CJ-16-0432

Smith JR, Medina-Inojosa JR, Layrisse V et al Clinical Medicine Predictors of Exercise Capacity in patients with hypertrophic obstructive cardiomyopathy. https://doi.org/10.3390/jcm7110447

Ommen SR, Mital S, Burke MA et al (2020) 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142:e558–e631. https://doi.org/10.1161/CIR.0000000000000937

Cecchi F, Charron P, Alain Hagege A, et al ESC et al GUIDELINES 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). https://doi.org/10.1093/eurheartj/ehu284

Mitchell C, Rahko PS, Blauwet LA et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 32:1–64. https://doi.org/10.1016/j.echo.2018.06.004

Muraru D, Niero A, Rodriguez-Zanella H et al (2018) Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. Cardiovasc Diagn Ther 8:101–117

Sugimoto T, Dulgheru R, Bernard A et al (2017) Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging 18:833–840. https://doi.org/10.1093/EHJCI/JEX140

Bernard A, Addetia K, Dulgheru R et al (2017) 3D echocardiographic reference ranges for normal left ventricular volumes and strain: results fromthe EACVI NORRE study. Eur Heart J Cardiovasc Imaging 18:475–483. https://doi.org/10.1093/ehjci/jew284

Saraiva RM, Scolin EMB, Pacheco NP et al 3-Dimensional Echocardiography and 2-D strain analysis of Left Ventricular, Left Atrial and right ventricular function in healthy brazilian volunteers. https://doi.org/10.5935/abc.20190155

Masri A, Pierson LM, Smedira NG et al (2015) Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography. Am Heart J 169:684–692e1. https://doi.org/10.1016/j.ahj.2015.02.006

Urbano-Moral JA, Rowin EJ, Maron MS et al (2014) Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 7:11–19. https://doi.org/10.1161/CIRCIMAGING.113.000842

Rakesh K, Rajesh GN, Vellani H (2021) 3D speckle tracking echocardiographic strain pattern in hypertrophic cardiomyopathy and its relation with Sudden Cardiac Death risk markers. Indian Heart J 73:451–457. https://doi.org/10.1016/j.ihj.2020.11.144

Pu C, Fei J, Lv S et al (2021) Global circumferential strain by Cardiac magnetic resonance tissue tracking Associated with ventricular arrhythmias in hypertrophic cardiomyopathy patients. Front Cardiovasc Med 8. https://doi.org/10.3389/fcvm.2021.670361

Inciardi RM, Galderisi M, Nistri S et al (2018) Echocardiographic advances in hypertrophic cardiomyopathy: three-dimensional and strain imaging echocardiography. Echocardiography 35:716–726

Aly MFA, Brouwer WP, Kleijn SA et al (2014) Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 30:523–533. https://doi.org/10.1007/s10554-014-0364-5